Cargando…

Relationship between NAFLD and coronary artery disease: A Mendelian randomization study

BACKGROUND AND AIMS: There is an ongoing debate on whether NAFLD is an active contributor or an innocent bystander in the pathogenesis of coronary artery disease (CAD). The aim of the present study was to assess the causal relationship between NAFLD and CAD. APPROACH AND RESULTS: We performed two‐sa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Zhewen, Simons, Pomme I. H. G., Wesselius, Anke, Stehouwer, Coen D. A., Brouwers, Martijn C. G. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Articles: Steatohepatitis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970021/ https://www.ncbi.nlm.nih.gov/pubmed/35441719 http://dx.doi.org/10.1002/hep.32534

Ejemplares similares

Causal relationship between polycystic ovary syndrome and coronary artery disease: A Mendelian randomisation study
por: Simons, Pomme I. H. G., et al.
Publicado: (2021)

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
por: Younossi, Zobair M., et al.
Publicado: (2023)

Relationship Between Nonalcoholic Fatty Liver Disease Susceptibility Genes and Coronary Artery Disease
por: Brouwers, Martijn C.G.J., et al.
Publicado: (2019)

The relationships of sex hormone‐binding globulin, total testosterone, androstenedione and free testosterone with metabolic and reproductive features of polycystic ovary syndrome
por: Simons, Pomme I. H. G., et al.
Publicado: (2021)

Association of common gene variants in glucokinase regulatory protein with cardiorenal disease: A systematic review and meta-analysis
por: Simons, Pomme I. H. G., et al.
Publicado: (2018)

The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent
por: Goikoetxea-Usandizaga, Naroa, et al.
Publicado: (2023)

Intestinal peroxisome proliferator‐activated receptor α‐fatty acid‐binding protein 1 axis modulates nonalcoholic steatohepatitis
por: Yan, Tingting, et al.
Publicado: (2023)

Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride‐rich lipoprotein metabolism
por: Deprince, Audrey, et al.
Publicado: (2023)

RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease
por: Afonso, Marta B., et al.
Publicado: (2023)

Myeloid p38 activation maintains macrophage–liver crosstalk and BAT thermogenesis through IL‐12–FGF21 axis
por: Crespo, María, et al.
Publicado: (2023)

Lipocalin‐2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high‐fat diet–fed Ob/Ob mice
por: Kim, Kyung Eun, et al.
Publicado: (2023)

Metabolic dysfunction‐associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality
por: van Kleef, Laurens A., et al.
Publicado: (2023)

Macrophage‐derived MLKL in alcohol‐associated liver disease: Regulation of phagocytosis
por: Wu, Xiaoqin, et al.
Publicado: (2023)

Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression
por: Juárez‐Fernández, María, et al.
Publicado: (2023)

The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories
por: Lazarus, Jeffrey V., et al.
Publicado: (2023)

Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study
por: Anstee, Quentin M., et al.
Publicado: (2023)

Head-to-head comparison of magnetic resonance elastography-based liver stiffness, fat fraction, and T1 relaxation time in identifying at-risk NASH
por: Li, Jiahui, et al.
Publicado: (2023)

Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness
por: Indira Chandran, Vineesh, et al.
Publicado: (2023)

Fatty liver disease is not associated with increased mortality in the elderly: A prospective cohort study
por: van Kleef, Laurens A., et al.
Publicado: (2023)

Hepatic mitochondrial NAD(+) transporter SLC25A47 activates AMPKα mediating lipid metabolism and tumorigenesis
por: Cheng, Lili, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality
por: Brouwers, Martijn C. G. J., et al.
Publicado: (2019)

Traditional lifestyle factors partly mediate the association of socioeconomic position with intrahepatic lipid content: The Maastricht study
por: Ren, Zhewen, et al.
Publicado: (2023)

Effect of Colesevelam on Liver Fat Quantified by Magnetic Resonance in Nonalcoholic Steatohepatitis: A Randomized Controlled Trial
por: Le, Thuy-Anh, et al.
Publicado: (2012)

Hypercaloric diets with increased meal frequency, but not meal size, increase intrahepatic triglycerides: A randomized controlled trial
por: Koopman, Karin E, et al.
Publicado: (2014)

Ezetimibe for the Treatment of Nonalcoholic Steatohepatitis: Assessment by Novel Magnetic Resonance Imaging and Magnetic Resonance Elastography in a Randomized Trial (MOZART Trial)
por: Loomba, Rohit, et al.
Publicado: (2015)

Dissociation Between APOC3 Variants, Hepatic Triglyceride Content and Insulin Resistance
por: Kozlitina, Julia, et al.
Publicado: (2011)

Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study
por: Simons, Pomme I. H. G., et al.
Publicado: (2022)

Effects of fructose restriction on liver steatosis (FRUITLESS); a double-blind randomized controlled trial
por: Simons, Nynke, et al.
Publicado: (2020)

Plasma metabolomic profiling of dietary patterns associated with glucose metabolism status: The Maastricht Study
por: Yu, Evan Yi-Wen, et al.
Publicado: (2022)

The small molecule, genistein, increases hepcidin expression in human hepatocytes
por: Zhen, Aileen W, et al.
Publicado: (2013)

Apolipoprotein CIII Overexpressing Mice Are Predisposed to Diet-Induced Hepatic Steatosis and Hepatic Insulin Resistance
por: Lee, Hui-Young, et al.
Publicado: (2011)

Assessing the causal relationships between human blood metabolites and the risk of NAFLD: A comprehensive mendelian randomization study
por: Guo, Ziwei, et al.
Publicado: (2023)

Relationship between de novo lipogenesis and serum sex hormone binding globulin in humans
por: Simons, Pomme I. H. G., et al.
Publicado: (2021)

Association between leptin and NAFLD: a two-sample Mendelian randomization study
por: Guo, Ziwei, et al.
Publicado: (2023)

A Phase 1/2, Dose-Escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE-Related Hereditary Hemochromatosis
por: Phatak, Pradyumna, et al.
Publicado: (2010)

Role of Patatin-Like Phospholipase Domain-Containing 3 on Lipid-Induced Hepatic Steatosis and Insulin Resistance in Rats
por: Kumashiro, Naoki, et al.
Publicado: (2013)

IL-17 Signaling Accelerates the Progression of Nonalcoholic Fatty Liver Disease in Mice
por: Harley, Isaac TW, et al.
Publicado: (2014)

Prospective evaluation of the diagnostic accuracy of hepatic copper content, as determined using the entire core of a liver biopsy sample
por: Yang, Xu, et al.
Publicado: (2015)

Magnetic Resonance Elastography Predicts Advanced Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: A Prospective Study
por: Loomba, Rohit, et al.
Publicado: (2014)

Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice
por: Gariani, Karim, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pn4qcm5546kchi5jtfpg0b59gf